ES2063332T3 - Solucion de infusion nefroprotectora. - Google Patents

Solucion de infusion nefroprotectora.

Info

Publication number
ES2063332T3
ES2063332T3 ES90900071T ES90900071T ES2063332T3 ES 2063332 T3 ES2063332 T3 ES 2063332T3 ES 90900071 T ES90900071 T ES 90900071T ES 90900071 T ES90900071 T ES 90900071T ES 2063332 T3 ES2063332 T3 ES 2063332T3
Authority
ES
Spain
Prior art keywords
nefroprotective
infusion solution
cytostatic
kidneys
protect
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES90900071T
Other languages
English (en)
Spanish (es)
Inventor
Hagen Bertermann
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
BETERMANN HAGEN
SKREZEK CHRISTIAN
Original Assignee
BETERMANN HAGEN
SKREZEK CHRISTIAN
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by BETERMANN HAGEN, SKREZEK CHRISTIAN filed Critical BETERMANN HAGEN
Application granted granted Critical
Publication of ES2063332T3 publication Critical patent/ES2063332T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/01—Hydrolysed proteins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/02—Antidotes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Toxicology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
ES90900071T 1988-12-22 1989-12-21 Solucion de infusion nefroprotectora. Expired - Lifetime ES2063332T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3843241A DE3843241A1 (de) 1988-12-22 1988-12-22 Nephroprotektive infusionsloesung

Publications (1)

Publication Number Publication Date
ES2063332T3 true ES2063332T3 (es) 1995-01-01

Family

ID=6369857

Family Applications (1)

Application Number Title Priority Date Filing Date
ES90900071T Expired - Lifetime ES2063332T3 (es) 1988-12-22 1989-12-21 Solucion de infusion nefroprotectora.

Country Status (8)

Country Link
EP (1) EP0408691B1 (cg-RX-API-DMAC10.html)
JP (1) JPH078790B2 (cg-RX-API-DMAC10.html)
AT (1) ATE110570T1 (cg-RX-API-DMAC10.html)
AU (1) AU4807990A (cg-RX-API-DMAC10.html)
DE (2) DE3843241A1 (cg-RX-API-DMAC10.html)
ES (1) ES2063332T3 (cg-RX-API-DMAC10.html)
RU (1) RU2077883C1 (cg-RX-API-DMAC10.html)
WO (1) WO1990006769A1 (cg-RX-API-DMAC10.html)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6224776B1 (en) 1996-05-24 2001-05-01 Cultor Corporation Method for fractionating a solution
US6096785A (en) * 1996-07-30 2000-08-01 Novartis Nutrition Ag Amino acid compositions and use thereof in treating renal dysfunction
UA65587C2 (en) * 1997-10-09 2004-04-15 Baker Norton Pharma Method for preventing nephrotoxicity induced by cyclosporins or tacrolimus
BR0008447A (pt) * 1999-02-23 2002-01-15 Univ California Métodos de tratamento de distúrbios mitocondriais
FI20010977A7 (fi) 2001-05-09 2002-11-10 Danisco Sweeteners Oy Kromatografinen erotusmenetelmä
EP1435910B9 (en) 2001-10-19 2010-02-03 Isotechnika Inc. Novel cyclosporin analog microemulsion preconcentrates
WO2005094813A1 (ja) * 2004-03-31 2005-10-13 Ajinomoto Co., Inc. 腎疾患用薬剤
US9669010B2 (en) 2012-12-06 2017-06-06 Bio Health Solutions, Llc Treatment for chronic kidney disease
PL2928461T3 (pl) * 2012-12-06 2020-02-28 Bio Health Solutions, Llc Leczenie przewlekłej choroby nerek

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3414491A1 (de) * 1984-04-17 1985-10-24 Hans Dr. 8202 Bad Aibling Dietl L-aminosaeurengemische fuer die parenterale und orale anwendung bei nierenerkrankungen

Also Published As

Publication number Publication date
RU2077883C1 (ru) 1997-04-27
JPH078790B2 (ja) 1995-02-01
DE58908288D1 (de) 1994-10-06
JPH03502805A (ja) 1991-06-27
DE3843241A1 (de) 1990-06-28
EP0408691B1 (de) 1994-08-31
WO1990006769A1 (de) 1990-06-28
EP0408691A1 (de) 1991-01-23
DE3843241C2 (cg-RX-API-DMAC10.html) 1990-11-22
AU4807990A (en) 1990-07-10
ATE110570T1 (de) 1994-09-15

Similar Documents

Publication Publication Date Title
GR1001503B (el) Μέ?οδος δια την παρασκευή φαρμακευτικών ενώσεων αι οποίαι περιέχουν ως δραστική ουσία καρβονικά οξέα τα οποία περιέχουν ?είον κα?ώς και η χρησιμοποίησις αυτών δια την καταπολέμησιν των ρετροιών.
AU4745990A (en) Syringe which automatically makes the hypodermic needle harmless after use
AU7405387A (en) Pharmaceutical compositions containing levodopa methyl ester, preparation and therapeutic applications thereof
IT1255449B (it) Uso di nor- e omo-derivati di acidi biliari come promotori di assorbimento di farmaci.
IT8822345A0 (it) Siringa con ago protetto.
DE69203990D1 (de) Einrichtung zur transdermalen Verabreichung von Medikamenten.
GR890100838A (el) Νέα ?εραπευτικώς δραστική ένωσις και μέ?οδος για την παραγωγή της.
ATA260690A (de) Therapeutische infusionszubereitung auf basis von aminosäurederivaten
PT929565E (pt) Esteres de nitrato de compostos corticoides e suas aplicacoes farmaceuticas
DE68920171D1 (de) Bipolarer gefilterter Durchführungsanschluss.
BG96323A (bg) Нов полипептид и анти-нiv лекарство,получено от него
DE69107493D1 (de) Arzneimittel zur transdermalen Verabreichung von Nitroglycerin.
DE58908288D1 (de) Nephroprotektive infusionslösung.
DE3867086D1 (de) Benzothiepino(5,4-c)pyridazin-verbindungen und ihre pharmazeutischen wirkungen.
ES2118248T3 (es) Esteres y amidas de 9-cloro-prostaglandina y su empleo para preparar medicamentos.
DE3885458D1 (de) Bauteil eines brennstoffeinspritzsystems.
FI884500A0 (fi) Foerfarande och apparatur foer avsaendning av binaera meddelanden i en seriell bussledning.
DE3671630D1 (de) Glycero-3(2)-phospho-l-serinderivate und diese enthaltende pharmazeutischen praeparate.
ATE169922T1 (de) Desoxyazaphospholipid-derivate mit inhibierender aktivität auf phospholipase
IT1222867B (it) Ftalazino derivati ad attivita' farmaceutica
FR2335232A1 (fr) Compositions pharmaceutiques a proprietes anticonvulsives contenant des phenylsilanes
FI892288A7 (fi) Triamtereenin farmaseuttiset liuokset
ES2091571T3 (es) Nuevos derivados peptidicos activos en los procesos de adhesion celular, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.
IT1216096B (it) L_piroglutamil_l_cisteina, dipeptide ad elevata attivita'anticatarattogena e composizioni farmaceutiche che lo contengono.
ATE40132T1 (de) 1,4-dihydropyridin-derivate und diese enthaltende pharmazeutische praeparate.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 408691

Country of ref document: ES